Asymmetric synthesis of functionalized pyrrolizidines by an organocatalytic and pot-economy strategy

Chia-Hsin Lina, Bor-Cherng Hong*a and Gene-Hsiang Leeb
aDepartment of Chemistry and Biochemistry, National Chung Cheng University, Chia-Yi 621, Taiwan, Republic of China. E-mail: chebch@ccu.edu.tw; Fax: +886 5 2721040; Tel: +886 5 2729174
bInstrumentation Center, National Taiwan University, Taipei 106, Taiwan, Republic of China

Received 26th November 2015 , Accepted 8th January 2016

First published on 13th January 2016


Abstract

An efficient method has been developed for the enantioselective synthesis of tetrahydro-1H-pyrrolizin-3(2H)-ones starting from α,β-unsaturated aldehydes via a sequence of asymmetric Michael–oxidative esterification–Michal–reduction–reductive amination–lactamization reactions with high enantioselectivities (93–97% ee). The six-step reaction sequence can be conducted with the pot-economy synthetic strategy with only a one-step purification. The structure and absolute stereochemistry of the intermediates and products were confirmed by X-ray analyses of appropriate products.


Indolizidine and the related azabicyclic ring systems constitute an important skeleton in many natural alkaloids with a wide spectrum of biological and pharmacological activities (Fig. 1). Owing to their biological activity and their scarcity in nature, many efforts have been devoted to the synthesis of these azabicyclic ring systems (Scheme 1). Among them, most syntheses have started from the natural chiral precursors, such as proline derivatives, or with the stoichimetric amount of chiral resources, and have been characterized by many steps of transformation. For example, total synthesis of the alkaloid (−)-absouline was accomplished in 8 steps by a key step reaction of a diastereoselective aminoconjugate addition to an enantiopure enoate,1 while the syntheses of (−)-isoretronecanol and/or (−)-trachelanthamidine were revealed from a L-proline derivative after many reaction steps (Scheme 1a).2 (−)-(R)-Pyrrolam A was synthesized via a key step reaction of a domino addition–Wittig alkenation reaction of (R)-benzyl prolinate with ylide the Ph3PCCO, immobilized on a polystyrene resin (Scheme 1b).3 In addition, (+)-laburnine was synthesized via a strategy of photoinduced radical conjugate addition of a tertiary amine to the chiral furanone (Scheme 1c),4 and (−)-isoretronecanol was synthesized with the strategy of enamino ester reduction and the chiral induction originating from (S)-α-methylbenzylamine (Scheme 1d).5
image file: c5ra25103f-f1.tif
Fig. 1 Select examples of naturally occurring pyrrolizidines and pyrrolizidine-3-ones.

image file: c5ra25103f-s1.tif
Scheme 1 Select examples of the approaches to pyrrolizidines and pyrrolizidine-3-ones.

Apart from using natural chiral precursors, asymmetric total syntheses of pyrrolizidine derivatives employing enantioselective reactions as key step have been much less reported. For example, the proline-catalyzed sequential α-amination and the Horner–Wadsworth–Emmons olefination of aldehyde was developed (Scheme 1e),6 and the synthesis of trifluorinated heliotridan was realized by the enantioselective Friedel–Crafts reaction of β-trifluoromethylated acrylates with pyrroles (Scheme 1f).7

Despite the aforementioned success in the synthesis of indolizidine derivatives, an efficient and alternative approach to the asymmetric synthesis of this system remains compellingly attractive.8 Accordingly, in an effort to expand our study of the application of organocatalysis,9 we envisaged that the pot-economy sequential reactions10 could provide an efficient protocol for the enantioselective synthesis of the indolizidine derivatives (Scheme 2). Our synthetic strategy started from the retrosynthetic disconnection of tetrahydro-1H-pyrrolizin-3(2H)-one via amidation and reductive Mannich reaction, leading to methyl 4-amino-7-oxoheptanoate. Subsequent reduction transformation and Michael transformation of the aminoester would provide the chiral methyl 3-alkyl-4-nitrobutanoate and acrolein. The chiral nitroester could be obtained from the one-pot asymmetric Michael addition–oxidative esterification of α,β-unsaturated aldehydes. Herein, we reveal the details of this approach and the synthetic protocol that provided an enantioselective synthesis of chiral enriched indolizidines with only a one-step purification (two-pot operation) by sequential asymmetric Michael–oxidative esterification–Michael–reduction–reductive Mannich–amidation reactions.


image file: c5ra25103f-s2.tif
Scheme 2 Retrosynthetic analysis of pyrrolizidine-3-one.

Initially, the γ-nitroesters 2 were prepared via a one-pot organocatalytic Michael addition–oxidative esterification of α,β-unsaturated aldehydes.11 A series of enals 1 and nitromethane were reacted with a catalytic amount (10 mol%) of Jørgensen-Hayashi catalyst (I)12 and benzoic acid (20 mol%) in MeOH at ambient temperature for 16 h (Table 1). Subsequently, the temperature of the solution was reduced to 4 °C and N-bromosuccinimide (NBS, 1.5–3.0 equiv.) was added to the reaction mixture, followed by stirring at 4 °C for 16 h. It is worth noting that the bromoproducts 2h and 2i were obtained in the reactions with the methoxy-substituted enals 1h and 1i. Via this one-pot protocol, the γ-nitroesters 2 were obtained in satisfactory yield, ranging from 53% to 66% with the enantioselectivity around 93–97% ee. The absolute stereochemistry of the γ-nitroesters was assigned unambiguously based on the X-ray analysis of a single crystal of (−)-2h (Fig. 2).

Table 1 Asymmetric Michael addition–oxidative esterification

image file: c5ra25103f-u1.tif

Entry R Yielda (%) eeb (%)
a Isolated yield.b Determined by HPLC with a chiral column (unless otherwise noted, by Chiralpak IB).c NBS (1.5 equiv.) was applied.d By Chiralpak IC.
1c 2a: R1 = H, R2 = H, R3 = H, R4 = H 58 95
2c 2b: R1 = H, R2 = F, R3 = H, R4 = H 62 94d
3 2c: R1 = H, R2 = Cl, R3 = H, R4 = H 66 94
4 2d: R1 = H, R2 = Br, R3 = H, R4 = H 60 94
5 2e: R1 = H, R2 = Me, R3 = H, R4 = H 53 96
6 2f: R1 = Br, R2 = H, R3 = H, R4 = H 58 97
7 2g: R1 = Cl, R2 = H, R3 = Me, R4 = H 60 96
8 2h: R1 = H, R2 = OMe, R3 = H, R4 = Br 57 93
9 2i: R1 = OMe, R2 = H, R3 = F, R4 = Br 58 96



image file: c5ra25103f-f2.tif
Fig. 2 Stereoplots of the X-ray crystal structures of (−)-2h: C, gray; O, red; N, blue; Br, purple.

The conjugate addition of nitroester 2a to acrolein was screened with a series of catalysts and additives in CH3CN (Table 2). Unusually, the reaction with triethyl amine (achiral base) provided the fastest completion and afforded the highest yield with highest diasteroselectivity (Table 2, entry 9).13 With the optimum reaction conditions in hand, a series of aminoesters 2 were reacted with acrolein and Et3N to afford nitroaldehydes 3 (Table 3). All reactions were completed in a day and with the yields ranging from 78% to 89%. The enantiomeric excess value of the products 3 remained the same, around 93–97% ee. Notably, for the case with 2g bearing the ortho-methyl substituent, different diasteroselectiviy favoring anti-3 was observed, perhaps owing to the steric bulkiness so close to the conjugate addition center (Table 3, entry 7).

Table 2 Michael reaction of 2a and acroleina

image file: c5ra25103f-u2.tif

Entry Cat. Additive Solvent Time (h) Yieldd (%) dre (syn-3a/anti-3a)
a Unless otherwise noted, the reactions were performed with catalyst-additive (20 mol%) in 0.1 M of 2a with a ratio of 1/2 of 2a and acrolein.b Recovered much starting materials (2a).c Additive (100 mol%).d Isolated yields.e Determined by the crude 1H NMR spectrum. nr = no reaction. na = not available.
1b II CH3CN 168 21 71[thin space (1/6-em)]:[thin space (1/6-em)]29
2b III CH3CN 168 36 67[thin space (1/6-em)]:[thin space (1/6-em)]33
3 IV CH3CN 168 nr nr
4 V CH3CN 144 52 47[thin space (1/6-em)]:[thin space (1/6-em)]53
5b I PhCO2H CH3CN 168 na na
6 I NEt3 CH3CN 50 32 72[thin space (1/6-em)]:[thin space (1/6-em)]28
7 II NEt3 CH3CN 44 38 74[thin space (1/6-em)]:[thin space (1/6-em)]26
8 III NEt3 CH3CN 24 61 68[thin space (1/6-em)]:[thin space (1/6-em)]32
9c NEt3 CH3CN 18 82 78[thin space (1/6-em)]:[thin space (1/6-em)]22
10c DIPEA CH3CN 17 71 75[thin space (1/6-em)]:[thin space (1/6-em)]25
11 DBU CH3CN 2 Trace na
12 DABCO CH3CN 18 47 69[thin space (1/6-em)]:[thin space (1/6-em)]31


Table 3 Michael reaction of 2 and acroleina

image file: c5ra25103f-u3.tif

Entry R Time (h) Yieldb (%) drc syn-3/anti-3 eed syn-3/anti-3
a The reactions were performed with NEt3 (1.0 equiv.) in 0.1 M of with a ratio of 1/2 of 2 and acrolein.b Isolated yields.c Determined by the crude 1H NMR spectrum.d Determined by HPLC with a chiral column (Chiralpak IC).
1 3a: R1 = H, R2 = H, R3 = H, R4 = H 18 82 78[thin space (1/6-em)]:[thin space (1/6-em)]22 96/96
2 3b: R1 = H, R2 = F, R3 = H, R4 = H 24 86 71[thin space (1/6-em)]:[thin space (1/6-em)]29 95/96
3 3c: R1 = H, R2 = Cl, R3 = H, R4 = H 22 84 64[thin space (1/6-em)]:[thin space (1/6-em)]36 95/96
4 3d: R1 = H, R2 = Br, R3 = H, R4 = H 22 82 70[thin space (1/6-em)]:[thin space (1/6-em)]30 94/94
5 3e: R1 = H, R2 = Me, R3 = H, R4 = H 17 89 80[thin space (1/6-em)]:[thin space (1/6-em)]20 96/96
6 3f: R1 = Br, R2 = H, R3 = H, R4 = H 20 80 71[thin space (1/6-em)]:[thin space (1/6-em)]29 96/96
7 3g: R1 = Cl, R2 = H, R3 = Me, R4 = H 19 83 33[thin space (1/6-em)]:[thin space (1/6-em)]67 97/97
8 3h: R1 = H, R2 = OMe, R3 = H, R4 = Br 13 81 70[thin space (1/6-em)]:[thin space (1/6-em)]30 93/94
9 3i: R1 = OMe, R2 = H, R3 = F, R4 = Br 16 77 75[thin space (1/6-em)]:[thin space (1/6-em)]25 97/97


Subsequently, the one-pot nitro reduction–reduction animation sequence of syn-3 was conducted with zinc powder (20 equiv.) in conc. aqueous HCl–MeOH (1[thin space (1/6-em)]:[thin space (1/6-em)]1 v/v, 0.1 mL) at 0 °C, followed by gradually warming to ambient temperature over 2 h. After the regular work up procedure (neutralization with aqueous NaHCO3, extraction with EtOAc and concentration), the residue was dissolved in MeOH and the solution was heated to 50 °C for 12 h, affording the tetrahydro-1H-pyrrolizin-3 (2H)-one syn-4 in 51–77% yields (Table 4). The structure and, in particular, the absolute configuration of (−)-syn-4g was assigned unambiguously based on the X-ray analysis of a single crystal (Fig. 3). In particular, the asymmetric synthetic methodology to tetrahydro-1H-pyrrolizin-3(2H)-one could provide a useful protocol in the indolizidine natural products synthesis. For example, syn-4a has been transformed to phenopyrrozin, a marine metabolite isolated from the fungi Chromocleista sp.14

Table 4 Nitro reduction–reductive amination–lactamization of syn-3

image file: c5ra25103f-u4.tif

Entry R Yielda
a Isolated yield.
1 syn-4a: R1 = H, R2 = H, R3 = H, R4 = H 78
2 syn-4b: R1 = H, R2 = F, R3 = H, R4 = H 51
3 syn-4c: R1 = H, R2 = Cl, R3 = H, R4 = H 61
4 syn-4d: R1 = H, R2 = Br, R3 = H, R4 = H 55
5 syn-4e: R1 = H, R2 = Me, R3 = H, R4 = H 63
6 syn-4f: R1 = Br, R2 = H, R3 = H, R4 = H 68
7 syn-4g: R1 = Cl, R2 = H, R3 = Me, R4 = H 66
8 syn-4h: R1 = H, R2 = OMe, R3 = H, R4 = Br 57
9 syn-4i: R1 = OMe, R2 = H, R3 = F, R4 = Br 60



image file: c5ra25103f-f3.tif
Fig. 3 Stereoplots of the X-ray crystal structures of (−)-syn-4g: C, gray; O, red; N, blue; Cl, green.

On the other hand, the same reaction protocol was applied in the reaction of anti-3 and gave the corresponding tetrahydro-1H-pyrrolizin-3(2H)-one anti-4 in good yields, 52–76% yields (Table 5).

Table 5 Nitro reduction–reductive amination–lactamization of anti-3

image file: c5ra25103f-u5.tif

Entry R Yielda
a Isolated yield.
1 anti-4a: R1 = H, R2 = H, R3 = H, R4 = H 76
2 anti-4b: R1 = H, R2 = F, R3 = H, R4 = H 52
3 anti-4c: R1 = H, R2 = Cl, R3 = H, R4 = H 55
4 anti-4d: R1 = H, R2 = Br, R3 = H, R4 = H 59
5 anti-4e: R1 = H, R2 = Me, R3 = H, R4 = H 55
6 anti-4f: R1 = Br, R2 = H, R3 = H, R4 = H 53
7 anti-4g: R1 = Cl, R2 = H, R3 = Me, R4 = H 66
8 anti-4h: R1 = H, R2 = OMe, R3 = H, R4 = Br 64
9 anti-4i: R1 = OMe, R2 = H, R3 = F, R4 = Br 59


Moreover, the four-step reaction, Michael–nitro reduction–reductive amination–lactamization, can be performed in a one-pot manner (Table 6). The isolated yields of 4 in this one-pot operation process were slightly higher than the corresponding stepwise operations from nitroester 2 and acrolein. The ee and dr of product 4 remained the same as that observed in the aforementioned aldehyde 3 isolation process.

Table 6 One-pot Michael–nitro reduction–reductive amination–lactamization

image file: c5ra25103f-u6.tif

Entry R Time (h) Yielda (%) drb syn-4/anti-4
a Isolated yield of pure syn-4/anti-4 mixture.b Determined by the crude 1H NMR spectrum.c Further separation by HPLC with a ZORBAX SIL column gave 39% yield of syn-4a and 12% yield of anti-4a.d 94% and 94% ee, respectively. Determined by HPLC with a chiral column (Chiralpak IC).
1 4a: R1 = H, R2 = H, R3 = H, R4 = H 18 57c 75[thin space (1/6-em)]:[thin space (1/6-em)]25
2 4d: R1 = H, R2 = Br, R3 = H, R4 = H 20 56 72[thin space (1/6-em)]:[thin space (1/6-em)]28d
3 4h: R1 = H, R2 = OMe, R3 = H, R4 = Br 13 53 68[thin space (1/6-em)]:[thin space (1/6-em)]32


Conclusions

In summary, we have reported an asymmetric synthesis of tetrahydro-1H-pyrrolizin-3(2H)-one from α,β-unsaturated aldehydes via a sequence of asymmetric Michael–oxidative esterification–Michael–reduction–reductive amination–lactamization with high enantioselectivities (93–97% ee). The six-step reaction sequence can be conducted with only a one-step purification, constituting the pot-economy synthetic strategy. The structures and absolute configurations of the products (−)-2h and (−)-syn-4g have been unambiguously confirmed by single crystal X-ray crystallographic analyses. Given the abundance of the indolizidine in nature, this efficient and asymmetric process could compose an effective protocol in a related natural product synthesis.14

Acknowledgements

We acknowledge the financial support for this study from the Ministry of Science and Technology (MOST, Taiwan) and thank the instrument center of MOST for analyses of compounds. Thanks to Arun Raja and Rui-You Xu for their help in the work.

Notes and references

  1. E. J. Eklund, R. D. Pike, R. Jonathan and J. R. Scheerer, Tetrahedron Lett., 2012, 53, 4644–4647 CrossRef CAS.
  2. (a) K. K. S. Reddy, B. V. Rao and S. S. Raju, Tetrahedron: Asymmetry, 2011, 22, 662–668 CrossRef CAS; (b) H. Ishibashi, M. Sasaki and T. Taniguchi, Tetrahedron, 2008, 64, 7771–7773 CrossRef CAS; (c) D. Craig, C. J. T. Hyland and S. E. Ward, Synlett, 2006, 2142–2144 CrossRef CAS.
  3. R. Schobert and A. Wicklein, Synthesis, 2007, 1499–1502 CrossRef CAS.
  4. S. Bertrand, N. Hoffmann and J.-P. Pete, Eur. J. Org. Chem., 2000, 2227–2238 CrossRef CAS.
  5. O. David, J. Blot, C. Bellec, M.-C. Fargeau-Bellassoued, G. Haviari, J.-P. Célérier, G. Lhommet, J.-C. Gramain and D. Gardette, J. Org. Chem., 1999, 64, 3122–3131 CrossRef CAS PubMed.
  6. S. V. Kauloorkar, V. Jha and P. Kumar, RSC Adv., 2013, 3, 18288–18291 RSC.
  7. Y. Huang, E. Tokunaga, S. Suzuki, M. Shiro and N. Shibata, Org. Lett., 2010, 12, 1136–1138 CrossRef CAS PubMed.
  8. For recent examples in the synthesis of tetrahydro-1H-pyrrolizin-3(2H)-one, see: (a) X. Feng, H.-L. Cui, S. Xu, L. Wu and Y.-C. Chen, Chem.–Eur. J., 2010, 16, 10309–10312 CrossRef CAS PubMed; (b) W.-Y. Xu, R. Iwaki, Y.-M. Jia, W. Zhang, A. Kato and C.-Y. Yu, Org. Biomol. Chem., 2013, 11, 4622–4639 RSC; (c) Y. Kothapalli, R. K. Puthukanoori and S. R. Alapati, Tetrahedron Lett., 2012, 53, 1891–1893 CrossRef CAS; (d) N. V. Lakshmi and P. T. Perumal, Tetrahedron Lett., 2013, 54, 1817–1820 CrossRef CAS; (e) S. Leśniak, R. B. Nazarski and B. Pasternak, Tetrahedron, 2009, 65, 6364–6369 CrossRef; (f) C. Thomassigny, G. Le Bouc and C. Greck, ARKIVOC, 2012, 8, 231–249 Search PubMed; (g) L. Zoute, G. Kociok-Köhn and C. G. Christopher, Org. Lett., 2009, 11, 2491–2494 CrossRef CAS PubMed.
  9. (a) V.-W. Yang, B.-C. Hong, H.-K. Kao, T.-H. Tu, J.-Y. Shen, C.-L. Chen, G.-H. Lee and P.-T. Chou, Org. Lett., 2015, 17, 5816–5819 CrossRef CAS PubMed; (b) A. Raja, B.-C. Hong and G.-H. Lee, Org. Lett., 2014, 16, 5756–5759 CrossRef CAS PubMed; (c) N. S. Dange, B.-C. Hong and G.-H. Lee, RSC Adv., 2014, 4, 59706–59715 RSC; (d) D.-H. Jhuo, B.-C. Hong, C.-W. Chang and G.-H. Lee, Org. Lett., 2014, 16, 2724–2727 CrossRef CAS PubMed; (e) B.-C. Hong, C.-W. Lin, W.-K. Liao and G.-H. Lee, Org. Lett., 2013, 15, 6258–6261 CrossRef CAS PubMed; (f) N. S. Dange, B.-C. Hong, C.-C. Lee and G.-H. Lee, Org. Lett., 2013, 15, 3914–3917 CrossRef CAS PubMed; (g) B.-C. Hong, W.-K. Liao, N. S. Dange and J.-H. Liao, Org. Lett., 2013, 15, 468–471 CrossRef CAS PubMed.
  10. For recent reviews: (a) B.-C. Hong, A. Raja and V. M. Sheth, Synthesis, 2015, 47, 3257–3285 CrossRef CAS; (b) B.-C. Hong and N. S. Dange, Cascade Reactions in Stereoselective Synthesis, in Stereoselective Synthesis of Drugs and Natural Products, ed. V. Andrushko and N. Andrushko, Wiley, 2013, ch. 21, pp. 581–621 Search PubMed.
  11. K. L. Jensen, P. H. Poulsen, B. S. Donslund, F. Morana and K. A. Jørgensen, Org. Lett., 2012, 14, 1516–1519 CrossRef CAS PubMed.
  12. (a) M. Marigo, T. C. Wabnitz, D. Fielenbach and K. A. Jørgensen, Angew. Chem., Int. Ed., 2005, 44, 794 CrossRef CAS PubMed; (b) Y. Hayashi, H. Gotoh, T. Hayashi and M. Shoji, Angew. Chem., Int. Ed., 2005, 44, 4212 CrossRef CAS PubMed; (c) B. S. Donslund, T. K. Johansen, P. H. Poulsen, K. S. Halskov and K. A. Jørgensen, Angew. Chem., Int. Ed., 2015, 54, 13860–13874 CrossRef CAS PubMed.
  13. For acyclic Michael adducts, the relatively low diastereoselectivity in the acyclic conjugate addition of nitroalkane to α,β-unsaturated carbonyl compounds is essential, and the high diastereoselectivity of such types of acyclic reactions is elusive and remains a compelling challenge. For examples, see: (a) T. Ogawa, S. Mouri, R. Yazaki, N. Kumagai and M. Shibasaki, Org. Lett., 2012, 14, 110–113 CrossRef CAS PubMed; (b) Q. Yao, Z. Wang, Y. Zhang, X. Liu, L. Lin and X. Feng, J. Org. Chem., 2015, 80, 5704–5712 CrossRef CAS PubMed; (c) X.-T. Guo, J. Shen, F. Sha and X.-Y. Wu, Synthesis, 2015, 47, 2063–2072 CrossRef CAS; (d) M.-Y. Han, H.-Z. Wang, W.-K. An, J.-Y. Jia, B.-C. Ma, Y. Zhang and W. Wang, Chem.–Eur. J., 2013, 19, 8078–8081 CrossRef CAS PubMed; (e) H. Gotoh, D. Okamura, H. Ishikawa and Y. Hayashi, Org. Lett., 2009, 11, 4056–4059 CrossRef CAS PubMed; (f) E. Rodrigo, J. L. G. Ruano and M. B. Cid, J. Org. Chem., 2013, 78, 10737–10746 CrossRef CAS PubMed.
  14. (a) Y. Kothapalli, R. K. Puthukanoori and S. R. Alapati, Tetrahedron Lett., 2012, 53, 1891–1893 CrossRef CAS; (b) J. H. Kim, S. Lee and S. Kim, Angew. Chem., Int. Ed., 2015, 54, 10875–10878 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental detail, spectroscopic characterization, HPLC analysis. CCDC 1420364 and 1420368. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra25103f

This journal is © The Royal Society of Chemistry 2016